CE vs JNJ · rev $5.09B vs P/E 17, rev $49.37B
Celanese Corporation (CE) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CE revenue for 2026-06-30 was $5.09B. Net income was $169.0M. CE currently screens at market cap $5.92B.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CE currently screens at market cap $5.92B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CE and JNJ stock pages for the full models.
Not investment advice.